Latest Venous thrombosis Stories
Rowan Foundation and National Blood Clot Alliance Join Forces to Help Prevent Life-Threatening Blood Clots Among Young Women ROCKVILLE, Md., Dec. 18, 2014 /PRNewswire/ -- The Alexandra L.
The Firm is representing plaintiffs in Xarelto lawsuits that allege the blood thinner caused life-threatening internal bleeding, other serious complications. New
A Request To Centralize Xarelto Lawsuits Alleging Xarelto Users Experience Uncontrolled Bleeding Due To Taking The Blood Thinner Is Under Consideration By the U.S.
Seven-fold lower incidence of VTE in patients treated with ISIS-FXI Rx compared with enoxaparin CARLSBAD, Calif., Dec. 7, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
The Firm is representing plaintiffs in Xarelto lawsuits who allegedly suffered uncontrollable internal bleeding and other complications related to its use. New
Findings presented at American Heart Association's Scientific Sessions add to growing body of data supporting safety and effectiveness of PRADAXA RIDGEFIELD, Conn., Nov.
The Firm is representing individuals in Xarelto lawsuits that allege use of the blood-thinning medication caused serious complications, including uncontrollable internal bleeding. New
The Firm is evaluating Xarelto lawsuits on behalf of patients who experienced uncontrollable internal bleeding, strokes, deep vein thrombosis, pulmonary embolism, or other complications allegedly
- Poster on research about investigational, specific antidote for PRADAXA also to be presented RIDGEFIELD, Conn., Nov. 10, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
- A trick or prank.